Dr. Yanagiya, Business Development Leader from ARCALIS will present a poster at the IMAPAC Oligonucleotides & Peptides World Asia Congress 2026, to be held at Sands Expo & Convention Centre in Singapore from June 30th to July 1st, 2026. We warmly invite conference attendees to visit our poster presentation.

【Event details】 Official website: Oligonucleotides & Peptides World Asia Congress 2026
Date: June 30th (Tue) -1st (Wed), 2026
Venue: Sands Expo & Convention Centre Access: Sands Expo & Convention Centre

【Poster presentation】
Title: ARCALIS: An Integrated CDMO Empowering the Future of mRNA-based Therapeutics from Design to Manufacturing
Presenter: Dr. Akiko Yanagiya

【Abstract】
ARCALIS, Inc. is a CDMO specializing in mRNA vaccines and therapeutics for infectious diseases and cancer, and rare diseases. We provide fully integrated services from mRNA design to large‑scale GMP manufacturing ensuring a seamless drug development for pharmaceutical and biotech companies. In this presentation, we introduce four proprietary technologies developed to advance the discovery and development of safe and effective mRNA therapeutics: (1) an organ‑selective mRNA delivery platform using LNPs with fine-tuning LNP composition, (2) a saRNA platform for effective and persistent protein expression, (3) An innovative codon optimization method based on mRNA stability prediction model by machine learning, named HARNA^TM, developed in collaboration with Hitachi, Inc., and (4) an optimized T7 RNA polymerase that minimizes dsRNA impurities to reduce undesirable immune response.